• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchFreenome
    Picture of Freenome logo

    FRNM — Freenome Share News

    $12.290.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedMid CapNeutral
    • Market Cap
      $1.32bn
    • Enterprise Value
      $1.32bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • FRNM Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    FRNM Dividends
    • Brief: Freenome Expands Personalized Cancer Detection Portfolio With Simplescreen Lung Test

      Tue 13:43
    • FDA approves Freenome's blood test for colorectal cancer screening (updated)

      27/07/2026 15:27
    • FDA approves Freenome's blood test for colorectal cancer screening

      27/07/2026 14:12
    • Brief: FDA Approves Freenome’S Simplescreen™ Crc Blood-Based Screening Test Abbott To Commercialize In The U.S.

      27/07/2026 13:09
    • Brief: Freenome And Perceptive Capital Solutions Corp Announce Business Combination Agreement

      05/12/2025 13:34

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.